Saldent Internacional S.r.l., Pharmaceutical Import Profile — Dominican Republic (DGFT 2022–2026)

Name: Saldent Internacional S.r.l., Pharmaceutical Import Records from India — 4 Products, $4.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Saldent Internacional S.r.l., — Pharmaceutical Importer Profile (2026) | 4 Products, $4.5M Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Saldent Internacional S.r.l.,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Caplin Point Laboratories Limited	$7.7M	437	99.3%
Argus Salud Pharma Llp	$52.3K	6	0.7%

Saldent Internacional S.r.l., sources from 2 verified Indian suppliers across 262 distinct formulations. The sourcing is highly concentrated — Caplin Point Laboratories Limited accounts for 99.3% of total imports, indicating a strategic single-source relationship.

What Formulations Does Saldent Internacional S.r.l., Import?

Formulation	Value	Ships
Gencloben 30g (gentamycin	$250.0K	5
Ampicillin tablets USP 1000MG	$250.0K	5
Cevitran (vitamin c chewable tablets	$198.5K	5
Clarithromycin tablets USP 500MG claritromicina tabletas recubiertas 500MG (coclarit 500) (claritromicina USP 500MG)	$192.0K	7
Gencloben 30g (gentamycin	$150.0K	3
Gencloben (gentamycin, betamethasone, clotrimazole cream) gencloben 30g (gentamicina +betametasona + clotrimazol crema)	$140.9K	6
Clarithromycin tablets USP 500MG

What Products Does Saldent Internacional S.r.l., Import?

Top Products by Import Value

1Clotrimazole$1.7M 2Gentamicin$1.7M 3Vitamin$842.5K 4Nystatin$312.6K

Saldent Internacional S.r.l., Therapeutic Categories — 3 Specializations

Saldent Internacional S.r.l., imports across 3 therapeutic categories, with Antifungals (44.3%), Antibiotics (37.2%), Nutritional Supplements (18.5%) representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Clotrimazole	Antifungals	$1.7M	41	1.8%	5
2	Gentamicin	Antibiotics	$1.7M	35	2.4%

Key Metrics

Total Import Value$4.5M

Products4

Shipments131

Categories3

CountryDominican Republic

#1 Rankings0

Indian Suppliers2

Formulations262

Top Categories

Antifungals44.3%

Antibiotics37.2%

Last updated: March 28, 2026

Saldent Internacional S.r.l., — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Saldent Internacional S.r.l. is a prominent pharmaceutical importer based in the Dominican Republic, specializing in the acquisition of finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. The company plays a pivotal role in the nation's pharmaceutical distribution network, ensuring the availability of essential medications across various therapeutic categories. Headquartered in Santo Domingo, Saldent Internacional S.r.l. operates as an independent entity without a publicly known parent company. Its strategic focus on importing a diverse range of pharmaceutical products underscores its commitment to meeting the healthcare needs of the Dominican population.

2Distribution Network

While specific details about Saldent Internacional S.r.l.'s warehouse locations and logistics capabilities are not publicly disclosed, the company's extensive import activities suggest a well-established distribution network within the Dominican Republic. The 131 shipments from India indicate a robust logistical framework capable of handling significant volumes of pharmaceutical products. This infrastructure likely supports comprehensive geographic coverage, ensuring timely and efficient delivery of medications to various regions within the country.

Supplier Relationship Intelligence — Saldent Internacional S.r.l.,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with 99.3% of its imports originating from a single supplier, Caplin Point Laboratories Limited. This single-source dependency could pose risks related to supply chain disruptions, such as production delays or quality control issues. However, the consistent volume of shipments—437 in total—suggests a stable and well-established relationship between Saldent Internacional S.r.l. and Caplin Point Laboratories Limited. The remaining 0.7% of imports from Argus Salud Pharma LLP indicates minimal diversification in sourcing.

2Supply Chain Resilience

The resilience of Saldent Internacional S.r.l.'s supply chain is closely tied to its reliance on Caplin Point Laboratories Limited. The absence of backup suppliers for the majority of its imports suggests potential vulnerabilities in the event of disruptions. Additionally, the limited diversity in imported formulations, with 262 unique products, may impact the company's ability to adapt to changing market demands. The shipping routes primarily from India to the Dominican Republic are well-established, but any geopolitical or logistical challenges could affect supply continuity. Regulatory compliance of Caplin Point Laboratories Limited, adhering to standards such as WHO GMP, is essential to ensure the quality and safety of imported products.

3Strategic Implications

The concentrated sourcing pattern of Saldent Internacional S.r.l. positions Caplin Point Laboratories Limited as a critical partner, potentially offering leverage in negotiations. For Indian exporters, this presents an opportunity to become alternative suppliers, especially if they can offer competitive pricing, reliable quality, and adherence to international regulatory standards. Diversifying the supplier base could also mitigate risks associated with single-source dependency, enhancing supply chain resilience.

TransData Nexus Research · Verified DGFT customs dataMar 2026

Importing Pharmaceuticals into Dominican Republic — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Dominican Republic

1Regulatory Authority & Framework

The Dominican Republic's pharmaceutical imports are regulated by the Ministry of Public Health and Social Assistance, specifically the Department of Drugs and Pharmacies (SESPAS). Key legislation includes the General Law on Health and Regulation No. 246-06 on Medicines, which govern the importation of pharmaceuticals, cosmetics, and personal hygiene products. Pharmaceuticals classified as prescription psychotropic substances or subject to Law No. 50-88 on Drugs and Controlled Substances are also covered by this legislation. Importers must obtain an import permit from SESPAS for controlled medicines, semi-finished products, raw materials, solvents, and precursor chemicals.

2Import Licensing & GMP

Import licensing requirements in the Dominican Republic stipulate that pharmaceutical products must be registered with the Ministry of Public Health. A Sanitary Register must be obtained for each trademark or product imported, valid for five years. Additionally, Good Manufacturing Practices (GMP) certification is mandatory, with recognition of EU GMP, WHO GMP, and PIC/S standards. Importers must ensure that their suppliers comply with these certifications to facilitate the import process.

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing to confirm their quality and safety. Stability requirements are enforced to ensure that products maintain their efficacy throughout their shelf life. Labeling must be in Spanish, providing clear information on usage, dosage, and storage. Serialization mandates are in place to enhance traceability and prevent counterfeit products from entering the market.

4Recent Regulatory Changes

Between 2024 and 2026, the Dominican Republic has implemented policy changes affecting pharmaceutical imports, including stricter enforcement of GMP certifications and enhanced labeling requirements. These changes aim to improve the quality and safety of imported pharmaceuticals. Importers must stay informed about these regulations to ensure compliance and maintain uninterrupted supply chains.

TransData Nexus Research · Dominican Republic regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Saldent Internacional S.r.l., identified across shipments using consignee name normalization, aggregating 2 name variants.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Saldent Internacional S.r.l.,'s capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 131 individual customs records matching Saldent Internacional S.r.l.,.
5.Supplier Verification: Saldent Internacional S.r.l., sources from 2 verified Indian suppliers across 262 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

4 Products Tracked

3 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Saldent Internacional S.r.l.,

Saldent Internacional S.r.l., — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Saldent Internacional S.r.l.,?

What Formulations Does Saldent Internacional S.r.l., Import?

What Products Does Saldent Internacional S.r.l., Import?

Top Products by Import Value

Saldent Internacional S.r.l., Therapeutic Categories — 3 Specializations

Import Portfolio — Top 4 by Import Value

Key Metrics

Top Categories

Saldent Internacional S.r.l., — Corporate Profile & Information

1Company Overview

2Distribution Network

Indian Suppliers

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — Saldent Internacional S.r.l.,

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Dominican Republic — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Saldent Internacional S.r.l., — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to Saldent Internacional S.r.l.,

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — Saldent Internacional S.r.l.,

What products does Saldent Internacional S.r.l., import from India?

Who supplies pharmaceuticals to Saldent Internacional S.r.l., from India?

What is Saldent Internacional S.r.l.,'s total pharmaceutical import value?

What therapeutic categories does Saldent Internacional S.r.l., focus on?

Get Full Saldent Internacional S.r.l., Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology